Literature DB >> 18794880

Post-translational regulation of PTEN.

X Wang1, X Jiang.   

Abstract

PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor regulates a variety of cellular processes including cell proliferation, growth, migration and death. This master regulator itself is also under deliberative regulation. Although the evidence for PTEN regulation and its significance in normal biology and disease is overwhelming, the mechanisms and exact functional consequences of PTEN regulation are far from clear. In this review, we discuss recent advances concerning post-translational regulation of PTEN in general, and in more detail about its regulation by ubiquitination. We also discuss some unsolved questions in the field and how they might be addressed in the future. We propose that the complex regulatory mechanisms of PTEN dictate how this tumor suppressor executes its distinct biological functions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18794880     DOI: 10.1038/onc.2008.242

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  56 in total

Review 1.  Genetic alterations of PTEN in human melanoma.

Authors:  Almass-Houd Aguissa-Touré; Gang Li
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

2.  PTEN in liver diseases and cancer.

Authors:  Marion Peyrou; Lucie Bourgoin; Michelangelo Foti
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

3.  Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function.

Authors:  Antonella Papa; Lixin Wan; Massimo Bonora; Leonardo Salmena; Min Sup Song; Robin M Hobbs; Andrea Lunardi; Kaitlyn Webster; Christopher Ng; Ryan H Newton; Nicholas Knoblauch; Jlenia Guarnerio; Keisuke Ito; Laurence A Turka; Andy H Beck; Paolo Pinton; Roderick T Bronson; Wenyi Wei; Pier Paolo Pandolfi
Journal:  Cell       Date:  2014-04-24       Impact factor: 41.582

4.  Distinct functional outputs of PTEN signalling are controlled by dynamic association with β-arrestins.

Authors:  Evelyne Lima-Fernandes; Hervé Enslen; Emeline Camand; Larissa Kotelevets; Cédric Boularan; Lamia Achour; Alexandre Benmerah; Lucien C D Gibson; George S Baillie; Julie A Pitcher; Eric Chastre; Sandrine Etienne-Manneville; Stefano Marullo; Mark G H Scott
Journal:  EMBO J       Date:  2011-06-03       Impact factor: 11.598

5.  Oncogenic tyrosine kinases target Dok-1 for ubiquitin-mediated proteasomal degradation to promote cell transformation.

Authors:  Justyna A Janas; Linda Van Aelst
Journal:  Mol Cell Biol       Date:  2011-05-02       Impact factor: 4.272

6.  Induction of apoptotic genes by a p73-phosphatase and tensin homolog (p73-PTEN) protein complex in response to genotoxic stress.

Authors:  Jason A Lehman; David L Waning; Christopher N Batuello; Rocky Cipriano; Madhavi P Kadakia; Lindsey D Mayo
Journal:  J Biol Chem       Date:  2011-08-26       Impact factor: 5.157

7.  The chaperone-assisted E3 ligase C terminus of Hsc70-interacting protein (CHIP) targets PTEN for proteasomal degradation.

Authors:  Syed Feroj Ahmed; Satamita Deb; Indranil Paul; Anirban Chatterjee; Tapashi Mandal; Uttara Chatterjee; Mrinal K Ghosh
Journal:  J Biol Chem       Date:  2012-03-15       Impact factor: 5.157

8.  PTEN is a protein tyrosine phosphatase for IRS1.

Authors:  Yuji Shi; Junru Wang; Sarat Chandarlapaty; Justin Cross; Craig Thompson; Neal Rosen; Xuejun Jiang
Journal:  Nat Struct Mol Biol       Date:  2014-05-11       Impact factor: 15.369

9.  NO signaling and S-nitrosylation regulate PTEN inhibition in neurodegeneration.

Authors:  Young-Don Kwak; Tao Ma; Shiyong Diao; Xue Zhang; Yaomin Chen; Janet Hsu; Stuart A Lipton; Eliezer Masliah; Huaxi Xu; Francesca-Fang Liao
Journal:  Mol Neurodegener       Date:  2010-11-10       Impact factor: 14.195

10.  Regulation of the Src homology 2 domain-containing inositol 5'-phosphatase (SHIP1) by the cyclic AMP-dependent protein kinase.

Authors:  Jun Zhang; Scott F Walk; Kodi S Ravichandran; James C Garrison
Journal:  J Biol Chem       Date:  2009-06-03       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.